Close Menu

The Centers for Disease Control and Prevention plans to ramp up the number of SARS-CoV-2 samples that are sequenced in the US, CNN reports.

CNN adds that the US has been criticized for its limited SARS-CoV-2 sequencing. It notes, for instance, that the US has contributed 57,000 SARS-CoV-2 sequences to the GISAID database, while the UK has submitted 141,000 sequences.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.